Low expression of CD39 on regulatory T cells as a biomarker for resistance to methotrexate therapy in rheumatoid arthritis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Low expression of CD39 on regulatory T cells as a biomarker for resistance to methotrexate therapy in rheumatoid arthritis
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 112, Issue 8, Pages 2509-2514
Publisher
Proceedings of the National Academy of Sciences
Online
2015-02-10
DOI
10.1073/pnas.1424792112
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genetic and epigenetic predictors of responsiveness to treatment in RA
- (2014) Darren Plant et al. Nature Reviews Rheumatology
- Dendritic cells tolerized with adenosine A2AR agonist attenuate acute kidney injury
- (2012) Li Li et al. JOURNAL OF CLINICAL INVESTIGATION
- Genetic polymorphisms in key methotrexate pathway genes are associated with response to treatment in rheumatoid arthritis patients
- (2012) S A Owen et al. PHARMACOGENOMICS JOURNAL
- Optimising treatment in rheumatoid arthritis: a review of potential biological markers of response
- (2011) P. Emery et al. ANNALS OF THE RHEUMATIC DISEASES
- Nucleosides from Phlebotomus papatasi Salivary Gland Ameliorate Murine Collagen-Induced Arthritis by Impairing Dendritic Cell Functions
- (2011) Vanessa Carregaro et al. JOURNAL OF IMMUNOLOGY
- The Pathogenesis of Rheumatoid Arthritis
- (2011) Iain B. McInnes et al. NEW ENGLAND JOURNAL OF MEDICINE
- MTHFR gene polymorphisms and outcome of methotrexate treatment in patients with rheumatoid arthritis: analysis of key polymorphisms and meta-analysis of C677T and A1298C polymorphisms
- (2011) S A Owen et al. PHARMACOGENOMICS JOURNAL
- 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative
- (2010) D. Aletaha et al. ANNALS OF THE RHEUMATIC DISEASES
- cAMP/CREB-mediated Transcriptional Regulation of Ectonucleoside Triphosphate Diphosphohydrolase 1 (CD39) Expression
- (2010) Hui Liao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Can rheumatoid arthritis responsiveness to methotrexate and biologics be predicted?
- (2009) C. Bansard et al. RHEUMATOLOGY
- Pharmacokinetics of oral methotrexate in patients with rheumatoid arthritis
- (2008) Judith M. Dalrymple et al. ARTHRITIS AND RHEUMATISM
- Regulatory T Cells and Immune Tolerance
- (2008) Shimon Sakaguchi et al. CELL
- Deletion of Cd39/Entpd1 Results in Hepatic Insulin Resistance
- (2008) K. Enjyoji et al. DIABETES
- Functional ENTPD1 Polymorphisms in African Americans With Diabetes and End-Stage Renal Disease
- (2008) D. J. Friedman et al. DIABETES
- Adenosine and inflammation: CD39 and CD73 are critical mediators in LPS-induced PMN trafficking into the lungs
- (2008) Jörg Reutershan et al. FASEB JOURNAL
- Adenosine receptors: therapeutic aspects for inflammatory and immune diseases
- (2008) György Haskó et al. NATURE REVIEWS DRUG DISCOVERY
- Suppression of inflammatory and immune responses by the A2A adenosine receptor: an introduction
- (2007) T M Palmer et al. BRITISH JOURNAL OF PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation